Kaken Pharmaceutical Co (4521) Q4 2025 Earnings Report

0 Followers

JP:4521 Q4 2025 EPS Results

Actual EPS¥19.70

Consensus EPS¥19.98

Beat/MissMissed by -¥0.29

One Year Ago EPS-¥140.89

Actual Revenue¥19.25B

Expected Revenue¥22.69B

Beat/MissMissed by -¥3.44B

YoY Revenue Growth+6.70%

QuarterQ4 2025

Date05/13/2026

TimeTBA

Conference CallWednesday, May 13, 2026

JP:4521 Upcoming Earnings

Kaken Pharmaceutical Co's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q2)	- / -	19.03	―
Aug 07, 2026	2026 (Q1)	- / 222.86	7.13	3025.67% (+215.73)
May 13, 2026	2025 (Q4)	19.98 / 19.70	-140.89	113.98% (+160.59)
Feb 06, 2026	2025 (Q3)	24.79 / 10.71	129.08	-91.70% (-118.37)
Nov 10, 2025	2025 (Q2)	- / 19.03	330.91	-94.25% (-311.88)
Aug 07, 2025	2025 (Q1)	- / 7.13	46.32	-84.61% (-39.19)
May 12, 2025	2024 (Q4)	- / -140.89	35.648	-495.23% (-176.54)
Feb 06, 2025	2024 (Q3)	- / 129.08	68.92	87.29% (+60.16)
Nov 08, 2024	2024 (Q2)	- / 330.91	41.19	703.37% (+289.72)
Aug 07, 2024	2024 (Q1)	- / 46.32	66.99	-30.86% (-20.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed